UCB’s Cimzia bags EU label extension
admin 6th August 2020 Uncategorised 0Drug is first biologic in Europe to be approved with a dose reduction label for axSpA patients More: UCB’s Cimzia bags EU label extension Source: News
read moreDrug is first biologic in Europe to be approved with a dose reduction label for axSpA patients More: UCB’s Cimzia bags EU label extension Source: News
read moreDraft guidance says some commonly used drug treatments should be avoided More: NICE updates guidance on chronic pain treatments Source: News
read moreVaccine was generally well-tolerated with only a few mild side-effects reported More: Novavax’s COVID-19 vaccine produces immune response in early study Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals